Skip to main content
FinSpry Logo
FinSpry
AARD logo
AARD
(NASDAQ)
Aardvark Therapeutics, Inc.
$5.06-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aardvark Therapeutics (AARD) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Aardvark Therapeutics, Inc.
AARD•Nasdaq Stock Market•Healthcare•Biotechnology

About Aardvark Therapeutics

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOTien-Li Lee
Founded2017
IPO DateFebruary 13, 2025
Employees40
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websiteaardvarktherapeutics.com
Phone858 225 7696
Address
4370 La Jolla Village Drive, Suite 1050 San Diego, California 92122 United States

Corporate Identifiers

CIK0001774857
CUSIP002942100
ISINUS0029421007
EIN82-1606367
SIC2834

Leadership Team & Key Executives

Dr. Tien-Li Lee M.D.
Chief Executive Officer, Secretary and Director
Nelson B. Sun M.B.A.
Chief Financial Officer and Chief Operating Officer
Dr. Manasi Sinha Jaiman M.D., M.P.H.
Chief Medical Officer
Dr. Timothy J. Kieffer Ph.D.
Chief Scientific Officer
Christian Zapf J.D.
General Counsel
Dr. Dvorit Samid Ph.D.
Executive Vice President of Medical Affairs
Dr. Zhenhuan Zheng Ph.D.
Chief Research Officer
Ron Lewis II, Ph.D.
Vice President and Head of CMC
Justin T. Stege Ph.D.
Vice President and Head of Project Management and Strategy
Danny Villeneuve
Chief Commercial Officer